Organizations will work together to eliminate variances and data discrepancies and ensure hospitals meet FDA reporting requirements CHICAGO–(BUSINESS WIRE)–The Society for Vascular Surgery® Vascular Quality Initiative® (SVS VQI), a nonprofit organization dedicated to improving vascular quality within hospitals and outpatient facilities, today announced its partnership with Symmetric Health Solutions, for the purpose of […]
Other News
Medtronic Receives CE Mark Approval for Radial Artery Access Portfolio
– Portfolio Features First Catheter Specifically Designed to Allow Neurointerventionalists Radial Artery Access, Delivers Advantages to Patients Treated for Stroke, Brain Aneurysms, Other Neurovascular Conditions – Now Available in the United Kingdom, Italy, Spain, Germany and France DUBLIN, Sept. 28, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today […]
Open Stent Solution closes €2.5M Seed financing round for its breakthrough open-stent TMVR device
AMIENS, France, Sept. 28, 2021 /PRNewswire/ — Open Stent Solution (OSS), a medtech start-up company developing the first open-stent heart valves, today announced the closing of a €2.5 million Seed financing round. The funding will support the development of its ribbon-shaped stented mitral valve for transcatheter replacement. OSS’ breakthrough device is the first-ever […]
Foldax Completes Enrollment in Early Feasibility Study for TRIA Biopolymer Surgical Aortic Heart Valve
SALT LAKE CITY–(BUSINESS WIRE)–Foldax®, Inc. today announced completion of enrollment in the U.S. early feasibility study of the TRIA™ surgical aortic heart valve. The TRIA valve reimagines the heart valve by combining the company’s proprietary biopolymer – LifePolymer™ – with an innovative valve design intended to resist calcification, withstand stresses […]
Neovasc REDUCER-I Study Published in EuroIntervention Journal
VANCOUVER and MINNEAPOLIS, Sept. 28, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced the publication of an article entitled, “Coronary sinus narrowing for the treatment of refractory angina: a multicentre prospective open-label clinical study (the REDUCER-I study)” in the September 2021 issue of the journal EuroIntervention. […]
ACARIX begins US expansion and appoints Helen Ljungdahl Round as President Acarix Inc
Acarix announced today that the company has appointed Ms. Helen Ljungdahl Round as head of the company’s newly established US subsidiary Acarix Inc. Helen will assume her position in September 2021 and build the US organization. She will be a member of Acarix AB’s Executive Management Group. Acarix is a […]
BioSig Selects Plexus Corp. as its Manufacturing Partner
Global leader in complex product design, supply chain, manufacturing, and aftermarket services to support the Company’s growth Westport, CT, Sept. 28, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity […]
SANUWAVE Health Provides Business Update
SUWANEE, GA, Sept. 28, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — SANUWAVE Health, Inc. (PINK: SNWV), a leading provider of next-generation wound care products, has announced that as of September 28, 2021, the Company’s shares will no longer be traded on the OTC Market Pink, or the “pink sheets,” due to the […]
Nanowear Receives FDA 510(k) Platform Clearance to Implement Forthcoming AI-based Diagnostics in its Closed Loop Hospital-at-Home Network
NEW YORK–(BUSINESS WIRE)–Nanowear, a leading hospital-at-home and remote diagnostic platform informed by proprietary cloth nanotechnology and AI, today announced that it received its third FDA 510(k) clearance and first software-only clearance as an end-to-end digital platform, illustrating unique capabilities available to enterprise customer channels across a broad spectrum of diagnostic […]
Stealth BioTherapeutics Presents Positive Elamipretide Data in Pediatric Cardiology at International Society for Heart Research North American Section Meeting 2021
Elamipretide data demonstrated improvement in mitochondrial function in pediatric cardiomyopathy BOSTON, Sept. 28, 2021 /PRNewswire/ — Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction, announced today the presentation of positive elamipretide data showing improvements in mitochondrial respiration […]



